ARCH and Population Health join China blitz with Haisco deal

Haisco Pharma partners with ARCH Venture's Bob Nelsen & Population Health Partners' Clive Meanwell to launch Sentivera in a $1.5B+ deal for ex-China rights to a type 2 inflammatory disease drug.

Raccontata daendpoints.news